Coffee may prevent some metabolic diseases (still rude to mainline it in public)

              Many of the small pleasures we cultivate as young people come back to bite us later. Fans of loud music end up with hearing loss of tinnitus. Drinking and smoking can damage the liver and lungs. But it seems one vice may offer more help than harm. In findings published in the  Journal of Clinical Endocrinology & Metabolism, scientists from Suzhou Medical College of Soochow University report that caffeine intake may have a preventative effect against such cardiometabolic diseases such as diabetes and stroke.

              Specifically, the researchers found that regular intake of coffee or caffeine from other sources had a correlation with lower rates of new-onset cardiometabolic multimorbidity, meaning two or more cardiometabolic diseases in the same individual.

              Lead author, Dr. Chaofu Ke, defined moderate intake as follows: “Consuming three cups of coffee, or 200-300 mg caffeine, per day might help to reduce the risk of developing cardiometabolic multimorbidity in individuals without any cardiometabolic disease.”

              Ke’s team reviewed data from the UK Biobank, eventually including 172,315 individuals between the ages of 37 and 73 for caffeine in general and a further 188,091 tea and coffee drinkers specifically.

              During my time at Columbia, the rule about coffee was “no mainlining it in public.” It seems those of us who became infused with the beans of java like Fremen in Spice may not be reaping the late-stage rewards: Moderate consumption showed the most pronounced effect.

              Read the study in The Journal of Clinical Endocrinology & Metabolism. < https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgae552/7754545?redirectedFrom=fulltext&login=false>

Xujia Lu, Xiaohong Zhu, Guochen Li, Luying Wu, Liping Shao, Yulong Fan, Chen-Wei Pan, Ying Wu, Yan Borné, Chaofu Ke, Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity, The Journal of Clinical Endocrinology & Metabolism, 2024;, dgae552, https://doi.org/10.1210/clinem/dgae552